Literature DB >> 29066188

Early hemoperfusion for emergency treatment of carbamazepine poisoning.

Xiangming Yang1, Shiyu Xin1, Yajie Zhang1, Tiegang Li2.   

Abstract

OBJECTIVES: To investigate the clinical value of early hemoperfusion (HP) in emergency treatment of carbamazepine (CBZ) poisoning.
METHODS: 104 patients with acute CBZ poisoning treated from August 2004 to October 2015 in the Emergency Department were reviewed. Patients were categorized into three groups: group A, who received HP treatment in the Emergency Department; group B, who received HP treatment in the blood purification room; and group C, who did not received HP treatment. Pharmacokinetic parameters of CBZ and remission of complications were compared among the three groups.
RESULTS: Both groups A and B had lower time to peak, area under curve and maximum concentration values than group C (P<0.05), and these kinetics indexes were significantly lower in group A than in group B (P<0.05). The mean retention times were 0.85±0.08, 1.20±0.15 and 2.52±0.29days in the three groups, respectively, and were significantly lower value in group A than in group B (P<0.05). The incidences of respiratory depression and seizure in group A were significantly lower than those of groups B and C (P<0.05). Group A had significantly higher Glasgow coma scale (GCS) scores at 4h after admission than the other two groups (P<0.05), and group B had significantly higher GCS scores than group C at 6h after admission (P<0.05).
CONCLUSIONS: Initiation of HP in the early treatment stage of CBZ poisoning upon admission to an emergency department can significantly reduce the plasma concentration and retention period of CBZ, relieve the symptoms and shorten the overall treatment period.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carbamazepine; Emergency department; Glasgow coma scale; Hemoperfusion; Pharmacokinetics

Mesh:

Substances:

Year:  2017        PMID: 29066188     DOI: 10.1016/j.ajem.2017.10.048

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  5 in total

1.  Extracorporeal Treatment for Methotrexate Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.

Authors:  Marc Ghannoum; Darren M Roberts; David S Goldfarb; Jesper Heldrup; Kurt Anseeuw; Tais F Galvao; Thomas D Nolin; Robert S Hoffman; Valery Lavergne; Paul Meyers; Sophie Gosselin; Tudor Botnaru; Karine Mardini; David M Wood
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-02       Impact factor: 10.614

Review 2.  Hemoperfusion: technical aspects and state of the art.

Authors:  Claudio Ronco; Rinaldo Bellomo
Journal:  Crit Care       Date:  2022-05-12       Impact factor: 19.334

3.  Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.

Authors:  Josée Bouchard; Greene Shepherd; Robert S Hoffman; Sophie Gosselin; Darren M Roberts; Yi Li; Thomas D Nolin; Valéry Lavergne; Marc Ghannoum
Journal:  Crit Care       Date:  2021-06-10       Impact factor: 9.097

4.  Hydroxyapatite reinforced inorganic-organic hybrid nanocomposite as high-performance adsorbents for bilirubin removal in vitro and in pig models.

Authors:  Yamin Chai; Zhuang Liu; Yunzheng Du; Lichun Wang; Jinyan Lu; Qian Zhang; Wenyan Han; Tingting Wang; Yameng Yu; Lisha Sun; Lailiang Ou
Journal:  Bioact Mater       Date:  2021-05-24

5.  Epidemiological analysis of single center of acute poisoning cases based on poisoning treatment platform.

Authors:  Shen Jun-Hua; Zhang Jin-Song; Qiao Li; Wang Lei; Zhu Bao-Feng; Li Jia; Liu Ying; Cheng Jian-Rong
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.